ChemoCentryx Inc reports results for the quarter ended in June - Earnings Summary

Churchill Capital XI

09/08/2021 22:43

* ChemoCentryx Inc  CCXI.OQ  reported a quarterly adjusted loss
of 56 cents​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 55 cents per share.
* Revenue fell 96.3% to $1.81 million from a year ago;  analysts
expected $4.85 million. 
* ChemoCentryx Inc's reported EPS for the quarter was a loss
of 56 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* ChemoCentryx Inc shares had risen by 13.9% this quarter and
lost 75.4% so far this year.
* The company reported a quarterly loss of $39.21 million.
* Wall Street's median 12-month price target for ChemoCentryx
Inc is $30.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated August 9 at 09:42 p.m.  ​All
figures in US dollars unless otherwise stated